All In Biotech

Drug Trial Radar · NCT00817635

A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension

A Phase II, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Multi-center, Dose Ranging Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo After 8 Weeks Treatment in Patients With Resistant Hypertension

Last checked: Nov 19, 2026Latest source record: Jun 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 155 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

155

Actual

Start

Dec 22, 2008

Primary completion

Oct 13, 2009

Study completion Oct 13, 2009

Sponsor

Lead sponsor
NovartisNovartis (NVS)
Sponsor type
Industry
Collaborators
Great Lakes Drug Development, Inc.; Integrium
First posted
Jan 6, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study assessed the blood pressure effect, safety and tolerability of LCI699 compared to placebo and eplerenone in participants with resistant hypertension.

Conditions

  • Hypertension

Interventions

  • LCI699Drug

    LCI699 oral capsules

  • EplerenoneDrug

    Eplerenone oral capsules

  • LCI699-matching PlaceboDrug

    LCI699-matching placebo oral capsules

  • Eplerenone-matching PlaceboDrug

    Eplerenone-matching placebo oral capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in MSSBP at Week 8 Last Observation Carried Forward (LOCF)Time frame: Baseline, Week 8

Locations

38 sites in 2 countries. Site status is shown where the registry gives one.

  • Horizon Research Group, Inc

    Mobile, Alabama

  • Cochise Clinical Research

    Sierra Vista, Arizona

  • Clinical Solutions Advantage

    Buena Park, California

  • Michael Waldman, MD

    Irvine, California

  • Long Beach Center for Clinical Research

    Long Beach, California

  • Clinical Trials Research

    Roseville, California

  • Orange County Research Center

    Tustin, California

  • Metro Clinical Research

    Littleton, Colorado

  • Meridien Research

    Bradenton, Florida

  • Clinical Research of So. Florida

    Coral Gables, Florida

  • Jacksonville Heart Center

    Jacksonville Beach, Florida

  • FPA Clinical Research

    Kissimmee, Florida

  • Accelovance

    Melbourne, Florida

  • Cardio-Pulminary Associates

    Plantation, Florida

  • Meridien Research

    St. Petersburg, Florida

  • Northwest Clinical Trials

    Boise, Idaho

  • Provident Clinical Research

    Addison, Illinois

  • Cedar-Crosse Research Centereet

    Chicago, Illinois

  • Provident Clinical Research

    Bloomington, Indiana

  • Accelovance

    South Bend, Indiana

  • Peter A. Holt

    Baltimore, Maryland

  • MD Medical Research

    Oxon Hill, Maryland

  • Chelsea Internal Medicine

    Chelsea, Michigan

  • New York Cardiovascular Associates

    New York, New York

  • Charlotte Clinical Research

    Charlotte, North Carolina

  • Northstate Clinical Research

    Lenoir, North Carolina

  • Community Research

    Cincinnati, Ohio

  • Tipton Medical & Diagnostic Center

    Tipton, Pennsylvania

  • Medical Research South

    Charleston, South Carolina

  • Mountain View Clinical Research Associates

    Greer, South Carolina

  • Clinical Research Associates, Inc

    Nashville, Tennessee

  • Punzi Medical Center

    Carrollton, Texas

  • KRK Medical Research

    Dallas, Texas

  • DCOL Center for Clinical Research

    Longview, Texas

  • Daniel Gottlieb, MD

    Burien, Washington

  • Rainier Clinical Research Center

    Renton, Washington

  • Gemini Scientific

    Madison, Wisconsin

  • Encode Clinic

    Reykjavik, SA, Iceland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.